The following article is meant to provide doctors of chiropractic with more [i]or[/i] less information that will enable them to knowledgeably discuss other available therapies with patients.

The following article is meant to provide doctors of chiropractic with more [i]or[/i] less information that will enable them to knowledgeably discuss other available therapies with patients.

INTRODUCTION

Percutaneous vertebroplasty (PV) was conceived and first performed in France according to the interventional neuroradiologist Herve Deramond in 19841 Deramond treated a destructive hemangioma at C2 by way of injecting bone cement into the affected bone This caused almost immediate pain relief. PV was subsequently establish to also relieve pain in vertebral compression fractures caused by means of osteoporosis.1,2 Dion and colleagues (Jensen DeNardo, and Mathis) introduced the technique into the United States in 1993 at the University of Virginia. These investigators focused their work primarily forward osteoporotic compression fractures and subsequently provided the first clinical series using PV in the United States.3 They lay the foundation of significant pain relief in 85 to 90% of patients treated for painful osteoporotic compression fractures. This was similar to early reports about PV from Europe Since that time, the conduct has grown in acceptance around the world and is becoming the standard of care for the treatment of pain associated with vertebral compression fractures (VCF)

Demographics of Vertebral Compression Fractures

VCF come to pass when the combined axial and bending loads in succession the spine exceed the vigor of the vertebral body.4 Reduction in the individual vertebral carcass strength may result from infiltrative processe created by means of benign or malignant tumors or, more commonly from bone mineral los precipitated on osteoporosis.57 Osteoporosis, which may be age-related (primary) or befitting to steroid use (secondary), is the greatest in quantity common cause of VCF in the United States.8

The osteoporotic population in the United States at risk of fracture is immense: between 700000 and 1200000 vertebral compression fractures present itself annually.8 Osteoporosis is greatest in somewhat old Caucasian females and is increasing yearly in the number of affected individuals.' In addition, significant numbers of fractures are occurring in patients receiving steroids for conditions of the like kind as cancer, collagen vascular disease, transplant therapy, and plain allergy or asthma.

Neoplastic disease, allowing less common than osteoporosis, is a well-known cause of painful VCF These fractures are commonly associated with metastatic cancer, myeloma, and with aggressive benign tumors as it is as bone hemangiomas. If the determination of the etiology of the fracture is uncertain, biopsy can introduce or accompany the PV. PV will not impair other therapeutic measures as it was as chemotherapy or radiotherapy. Because the vertebra is frequently partially destroyed by malignant lesions, the risk of bond of union leaks during PV is greater than during treatment for osteoporosis. PV however, is known to provide virtuous pain relief in selected individuals with metastatic vertebral destruction and may be a upright alternative for treatment since pain relief is a great deal of faster than with radiation or chemotherapy.

Patient Selection for Vertenroplasty

Patients fix uponed for PV should have a painful vertebral compression fracture.3,10-23 Without PV chronic pain in these individuals may typically last from 2 weeks to 3 months24 The time between fracture and therapy may be defered by failed attempts at conservative management or delayed referral. admitting there are no absolute exclusionary criteria based onward the time between fracture and PV ancient fractures (>3 months) are les likely to have beneficial proceeds from PV unless one can point out to signs of nonunion or signs of renewed fracture. Nonunion is indicated by dint of persistent motion noted on fluoroscopy and can signify osteonecrosis (Kummell's disease). Other spinal entities, in the same state [i]or[/i] condition as herniated nucleus pulposus, facet arthropathy, and spinal stenosis may be not absent and complicate the evaluation. For this reason, imaging that provides physiologic information about the fracture is normally used to help pick out patients for PV. The preferr imaging process is magnetic resonance (MR), moreover nuclear medicine can also be used when MR is preclud (as in patients with pacemakers) or not available. The typical MR imaging finding in VCF is los of signal onward the TI weighted image and bright signal forward inversion recovery (IR) images. (Fig. 1) These signal changes are proper to marrow edema resulting from the compression fracture and are not seen in antiquated or healed compression injuries. This difference allows single to exclude old fractures from consideration for PV

Bone scans may also be helpful to assess problematic VCF(s) when used as a secondary screening tool. Nevertheless, MR imaging is preferr whenever possible because of the anatomic detail and information about other abnormalities (such as spinal stenosis, disk herniation, or tumor extension in the epidural space) that impacts decisions about the use of PV Bone scans are sensitive in detecting VCF and a negative bone scan, like a negative MR image, indicates a depressed likelihood of pain relief after PV therapy. Bone scans, however, can be positive in extent after substantial healing of a VCF has occurr This fact, coupl with the more restricted anatomic information (as compared with MR imaging), makes bone scans preferable no other than when MR imaging cannot be performed.